title: Oral leishmaniasis in an HIV-positive patient caused by two different zymodemes of Leishmania infantum.
authors.affiliation: Servicio de Microbiología, Hospital de la Santa Creu i Santa Pau, Barcelona, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Cortés
authors.forename: N
authors.initials: N
authors.lastname: Cardeñosa
authors.forename: J
authors.initials: J
authors.lastname: Romaní
authors.forename: M
authors.initials: M
authors.lastname: Gállego
authors.forename: C
authors.initials: C
authors.lastname: Muñoz
authors.forename: J L
authors.initials: JL
authors.lastname: Barrio
authors.forename: C
authors.initials: C
authors.lastname: Riera
authors.forename: M
authors.initials: M
authors.lastname: Portús
mesh_terms: D000328:Adult; D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D007527:Isoenzymes / Q000032:analysis; D018314:Leishmania infantum / Q000145:classification*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000469:parasitology*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009059:Mouth Diseases / Q000469:parasitology*; D009942:Organometallic Compounds / Q000627:therapeutic use
chemical_list: D000981:Antiprotozoal Agents; D007527:Isoenzymes; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony